Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis.
about
Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major.Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cellsDevelopment of a safe live Leishmania vaccine line by gene replacement.Impact of neutrophil-secreted myeloid related proteins 8 and 14 (MRP 8/14) on leishmaniasis progression.Synthetic oxoisoaporphine alkaloids: in vitro, in vivo and in silico assessment of antileishmanial activities.Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected miceIn vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensisAnimal models for the analysis of immune responses to leishmaniasis.Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine modelEffect of ambient temperature on the clinical manifestations of experimental diffuse cutaneous leishmaniasis in a rodent modelTissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.Granulocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death.Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.Pathophysiology of experimental leishmaniasis: pattern of development of metastatic disease in the susceptible hostResistance to cutaneous leishmaniasis: acquired ability of the host to kill parasites at the site of infection.Polymerase chain reaction detection and inducible nitric-oxide synthase expression of Leishmania major in mice inoculated by two different routes.Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.A real-time PCR assay for quantification of parasite burden in murine models of leishmaniasis
P2860
Q33599537-3A9EB65F-DCA9-4B4F-95A4-4C1CD71F20B8Q33607724-CE7720A0-6E01-47F3-A37A-343CD59F9174Q33830649-4EDA76B9-ED4D-42F6-B44C-04FC080C37F3Q35006545-5AFF95AD-A58B-4B5E-9B63-3E394215C7F8Q35035380-4DF2AEE6-EAFC-42E4-A9E8-C75F088D7A74Q35118989-638EF84F-D05F-425A-848D-6491008C0C89Q35128720-E0636405-4017-40A8-864B-E120D654DF1DQ35188674-2E764459-38A7-424C-9D22-6D53735A7F8EQ35548417-88054E8B-9C92-4046-80B9-EB2D4C62A3BCQ36302981-F40E9FCA-B5D4-419B-B39D-9FD9AD835FDDQ36363619-8EA3B0F3-0763-4919-952E-11CDF9996636Q36366480-A486BF02-0850-421C-BD22-BE044983B414Q36950287-C6EAE8BB-9013-438C-AD5C-010235A60148Q37002664-A4C29F1D-B475-4202-B157-70758C5CFC7BQ37028787-78B8CFA3-2484-4451-8675-397F2A9967ECQ37077346-60442878-1A6A-4F7A-988D-B2BF1DA8E268Q38776366-DFB3A1EB-7446-46EE-B4E5-CB60D6EE6CABQ38937093-C01BF28B-44DB-4CCF-98FB-793725914B20Q39954346-B7FE283C-42E5-40FC-9872-0CDE59DEEFFFQ42112456-1E8EF151-9797-40C9-AA44-7BE2554C61C3Q59137960-473B340C-980F-4721-804D-E81EBE71AB92
P2860
Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Advantages of measuring change ...... ental cutaneous leishmaniasis.
@ast
Advantages of measuring change ...... ental cutaneous leishmaniasis.
@en
type
label
Advantages of measuring change ...... ental cutaneous leishmaniasis.
@ast
Advantages of measuring change ...... ental cutaneous leishmaniasis.
@en
prefLabel
Advantages of measuring change ...... ental cutaneous leishmaniasis.
@ast
Advantages of measuring change ...... ental cutaneous leishmaniasis.
@en
P2093
P2860
P1476
Advantages of measuring change ...... mental cutaneous leishmaniasis
@en
P2093
P2860
P304
P407
P577
1983-03-01T00:00:00Z